| Chimeric antigen receptor (CAR)-based cell therapy for type 1 diabetes mellitus (T1DM); current Progress and future approaches V Mohammadi, AJ Maleki, M Nazari, A Siahmansouri, A Moradi, R Elahi, ... Stem Cell Reviews and Reports 20 (3), 585-600, 2024 | 7 | 2024 |
| The role of heat shock proteins (HSPs) in type 2 diabetes mellitus pathophysiology A Esmaeilzadeh, V Mohammadi, R Elahi, N Rezakhani Journal of Diabetes and its Complications, 108564, 2023 | 6 | 2023 |
| Transforming growth factor β (TGF-β) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches A Esmaeilzadeh, V Mohammadi, R Elahi Molecular Biology Reports 50 (7), 6121-6131, 2023 | 6 | 2023 |
| IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches R Elahi, M Nazari, V Mohammadi, K Esmaeilzadeh, A Esmaeilzadeh Molecular Immunology 171, 66-76, 2024 | 4 | 2024 |
| IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches R Elahi, M Nazari, V Mohammadi, K Esmaeilzadeh, A Esmaeilzadeh | 2 | 2023 |
| Association of chronotype and timing of interferon injection with severity of IFNβ-induced flu-like syndrome in Multiple sclerosis (MS) patients M Maghbooli, M Karami, V Mohammadi Journal of Clinical Neuroscience 128, 110811, 2024 | | 2024 |
| Application of magnetic nanoparticles in adoptive cell therapy of cancer; training, guiding and imaging cells V Mohammadi, K Esmaeilzadeh, A Esmaeilzadeh Nanomedicine, 1-15, 2024 | | 2024 |
| Nanobody-based chimeric antigen receptor (NbCAR) T cells for in-vivo cancer immunotherapy: A systematic review F Ebrahimi, M Jabbari, V Mohammadi, P Karami, K Esmaeilzadeh, ... | | 2024 |
| Targeted delivery of interleukin‐12 plasmid into HepG2 cells through folic acid conjugated graphene oxide nanocarrier F Safari, H Bardania, A Dehshahri, S Hallaj‐Nezhadi, A Asfaram, ... Biotechnology Progress, e3473, 2023 | | 2023 |
Abdolreza EsmaeilzadehProfessor of Immunology, Cancer Gene Therapy Research Center,Zanjan Uni of medical Sciences在 zums.ac.ir 的电子邮件经过验证
